CLINICAL TRIALS PROFILE FOR NALTREXONE
⮫ Send this page by email
✉ Email this page to a colleague
« Back to Dashboard
All Clinical Trials for NALTREXONE
Trial ID
Title
Status
Sponsor
Phase
Start Date
Summary
NCT00000195 ↗ Neurobiology of Opioid Dependence: 4 - 4
Withdrawn
National Institute on Drug Abuse (NIDA)
Phase 2
1993-01-01
The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on
the response to yohimbine in healthy volunteers.
NCT00000195 ↗ Neurobiology of Opioid Dependence: 4 - 4
Withdrawn
Yale University
Phase 2
1993-01-01
The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on
the response to yohimbine in healthy volunteers.
NCT00000196 ↗ Neurobiology of Opioid Dependence: 5 - 5
Withdrawn
National Institute on Drug Abuse (NIDA)
Phase 2
1993-01-01
The purpose of this study is to determine the effect of acute naltrexone pretreatment on the
response to yohimbine in healthy volunteers.
NCT00000196 ↗ Neurobiology of Opioid Dependence: 5 - 5
Withdrawn
Yale University
Phase 2
1993-01-01
The purpose of this study is to determine the effect of acute naltrexone pretreatment on the
response to yohimbine in healthy volunteers.
NCT00000230 ↗ Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
1995-01-01
The purpose of this study is to evaluate buprenorphine and behavioral treatment with and
without contingent payment on compliance with naltrexone.
NCT00000230 ↗ Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
Completed
University of Vermont
Phase 2
1995-01-01
The purpose of this study is to evaluate buprenorphine and behavioral treatment with and
without contingent payment on compliance with naltrexone.
>Trial ID
>Title
>Status
>Phase
>Start Date
>Summary
Clinical Trial Conditions for NALTREXONE
Condition Name
Condition Name for NALTREXONE
Intervention
Trials
Alcoholism
55
Alcohol Dependence
50
Obesity
28
Opioid Dependence
20
[disabled in preview]
0
Subscribe for full access, or try a Trial
Condition MeSH
Condition MeSH for NALTREXONE
Intervention
Trials
Alcoholism
124
Opioid-Related Disorders
97
Disease
50
Substance-Related Disorders
33
[disabled in preview]
0
Subscribe for full access, or try a Trial
Clinical Trial Locations for NALTREXONE
Trials by Country
Trials by Country for NALTREXONE
Location
Trials
United States
816
Canada
15
Germany
13
China
12
Russian Federation
11
Subscribe for full access, or try a Trial
Trials by US State
Trials by US State for NALTREXONE
Location
Trials
New York
69
Connecticut
58
California
54
Pennsylvania
53
Texas
38
Subscribe for full access, or try a Trial
Clinical Trial Progress for NALTREXONE
Clinical Trial Phase
Clinical Trial Phase for NALTREXONE
Clinical Trial Phase
Trials
Phase 4
104
Phase 3
62
Phase 2/Phase 3
36
[disabled in preview]
224
Subscribe for full access, or try a Trial
Clinical Trial Status
Clinical Trial Status for NALTREXONE
Clinical Trial Phase
Trials
Completed
303
Recruiting
58
Not yet recruiting
47
[disabled in preview]
49
Subscribe for full access, or try a Trial
Clinical Trial Sponsors for NALTREXONE
Sponsor Name
Sponsor Name for NALTREXONE
Sponsor
Trials
National Institute on Drug Abuse (NIDA)
96
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
61
Yale University
39
[disabled in preview]
82
Subscribe for full access, or try a Trial
Sponsor Type
Sponsor Type for NALTREXONE
Sponsor
Trials
Other
523
NIH
180
Industry
133
[disabled in preview]
25
Subscribe for full access, or try a Trial
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
